Gerontology Investigators Press An Ambitious Agenda

Sidebar: WHERE GERONTOLOGISTS GET TOGETHER ACCESSING AGING ASSETS Despite a substantial increase in the flow of financial support for gerontological research during the past several years, ambitious investigators of aging-associated phenomena continue to lament that their field is underfunded. One such investigator is Denham Harman, a professor, emeritus, at the University of Nebraska College of Medicine in Omaha. The 78-year-old

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Despite a substantial increase in the flow of financial support for gerontological research during the past several years, ambitious investigators of aging-associated phenomena continue to lament that their field is underfunded.

One such investigator is Denham Harman, a professor, emeritus, at the University of Nebraska College of Medicine in Omaha. The 78-year-old Harman for many years has argued that aging research deserves far more attention and financial support than it traditionally has received--especially because the United States population, according to demographic statistics, is rapidly getting older. "We need to spend more money on basic biomedical research on aging to go after its basic causes," he asserts.

Harman acknowledges his gratification at seeing significant funding gestures in the past year alone by such private sources as the Charles A. Dana Foundation in New York and the Glenn Foundation for Medical Research in Santa Barbara, Calif. And he was heartened most recently ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Karen Kreeger

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide